AIA - Anti HCV, Hbeag (Non-Fasting) near me in Hyderabad

The HBeAg (Hepatitis B Envelope Antigen) test measures the presence of the HBeAg in the blood, indicating active viral replication. A positive result signifies that the virus is replicating at a high level, suggesting a higher risk of transmission to others and potential progression to more severe liver disease. Conversely, a negative result may indicate lower viral activity or that the virus is in a non-replicative state.

Understanding the significance of HBeAg status is crucial in managing chronic hepatitis B infection. It helps guide treatment decisions, informs about the potential for liver damage, and aids in assessing the effectiveness of therapeutic interventions. Regular monitoring through this test can play a pivotal role in maintaining liver health and preventing complications associated with chronic hepatitis B.

An Hepatitis C Antibody (HCV), Rapid Screening Test test determines if HCV has infected you and helps your doctor guide your treatment. This is a rapid card based immunochromatographic test which is used for screening purposes only. A reactive result needs to be confirmed by other more specific NAT/ nucleic acid tests before final diagnosis.

HCV causes liver inflammation and is classified into acute hepatitis infection and chronic hepatitis infection.

• Acute hepatitis C: This occurs in the first six months after exposure to the hepatitis C virus. In the early stage of the infection, acute hepatitis C is mild and may cause no symptoms. For this reason, most people do not know they have this infection.

• Chronic hepatitis C: If your body cannot fight off the virus, you can develop a chronic hepatitis C infection. Progression from acute to chronic hepatitis C is common, occurring in 75-85% of patients. Detecting chronic hepatitis C early is important to prevent future complications, such as liver failure, and initiate effective treatment.